Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/12760
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMoonmuang S.
dc.contributor.authorSaoin S.
dc.contributor.authorChupradit K.
dc.contributor.authorSakkhachornphop S.
dc.contributor.authorIsrasena N.
dc.contributor.authorRungsiwiwut R.
dc.contributor.authorTayapiwatana C.
dc.date.accessioned2021-04-05T03:05:37Z-
dc.date.available2021-04-05T03:05:37Z-
dc.date.issued2018
dc.identifier.issn1448463
dc.identifier.other2-s2.0-85052957177
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/12760-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85052957177&doi=10.1042%2fBSR20181109&partnerID=40&md5=bca53f2880a16d21efb8f71e053657a0
dc.description.abstractLentiviral vectors have emerged as the most efficient system to stably transfer and insert genes into cells. By adding a tetracycline (Tet)-inducible promoter, transgene expression delivered by a lentiviral vector can be expressed whenever needed and halted when necessary. Here we have constructed a doxycycline (Dox)-inducible lentiviral vector which efficiently introduces a designed zinc finger protein, 2-long terminal repeat zinc-finger protein (2LTRZFP), into hematopoietic cell lines and evaluated its expression in pluripotent stem cells. As a result this lentiviral inducible system can regulate 2LTRZFP expression in the SupT1 T-cell line and in pluripotent stem cells. Using this vector, no basal expression was detected in the T-cell line and its induction was achieved with low Dox concentrations. Remarkably, the intracellular regulatory expression of 2LTRZFP significantly inhibited HIV-1 integration and replication in HIV-inoculated SupT1 cells. This approach could provide a potential tool for gene therapy applications, which efficiently control and reduce the side effect of therapeutic genes expression. © 2018 The Author(s).
dc.subjectdoxycycline
dc.subjectlentivirus vector
dc.subjectprotein 2LTR
dc.subjecttetracycline
dc.subjectunclassified drug
dc.subjectzinc finger protein
dc.subjectdoxycycline
dc.subjecttetracycline
dc.subjectzinc finger protein
dc.subjectantiviral activity
dc.subjectArticle
dc.subjectcontrolled study
dc.subjectgene expression
dc.subjectgene therapy
dc.subjecthematopoietic cell line
dc.subjectHuman immunodeficiency virus 1 infection
dc.subjectnonhuman
dc.subjectpluripotent stem cell
dc.subjectprotein expression
dc.subjectprotein stability
dc.subjectSUP-T1 cell line
dc.subjectT lymphocyte
dc.subjecttherapy effect
dc.subjectvirus DNA cell DNA interaction
dc.subjectvirus induction
dc.subjectvirus interference
dc.subjectvirus replication
dc.subjectdose response
dc.subjectdrug effect
dc.subjectgene expression regulation
dc.subjectgene vector
dc.subjectgenetics
dc.subjectHEK293 cell line
dc.subjecthuman
dc.subjectHuman immunodeficiency virus 1
dc.subjectHuman immunodeficiency virus infection
dc.subjectLentivirus
dc.subjectlong terminal repeat
dc.subjectpathogenicity
dc.subjectphysiology
dc.subjectprocedures
dc.subjecttransgene
dc.subjectvirology
dc.subjectvirus DNA cell DNA interaction
dc.subjectDose-Response Relationship, Drug
dc.subjectDoxycycline
dc.subjectGene Expression Regulation
dc.subjectGenetic Therapy
dc.subjectGenetic Vectors
dc.subjectHEK293 Cells
dc.subjectHIV Infections
dc.subjectHIV Long Terminal Repeat
dc.subjectHIV-1
dc.subjectHumans
dc.subjectLentivirus
dc.subjectPluripotent Stem Cells
dc.subjectTetracycline
dc.subjectTransgenes
dc.subjectVirus Integration
dc.subjectZinc Fingers
dc.titleModulated expression of the HIV-1 2LTR zinc finger efficiently interferes with the HIV integration process
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationBioscience Reports. Vol 38, No.5 (2018)
dc.identifier.doi10.1042/BSR20181109
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.